sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Íâ¿ÆÊÖÊõ»ò´´ÉË
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Ƥ·ô¹Ç÷À¼¡ÏµÍ³Ä£×Ó > Íâ¿ÆÊÖÊõ»ò´´ÉË

ǰÑÔ

¹ÇÊàŦÑ×(osteoarthritis, OA)ÊÇÖ÷ÒªÀÛ¼°ÖÐÍíÄêÈËȺµÄÂýÐÔÍËÐÐÐÔÊàŦ¼²²¡£¬ÒÔ¾ÙÐÐÐÔµÄÊàŦÈí¹ÇÍ˱䡢»¬Ä¤Ñ×Ö¢¡¢Èí¹ÇϹǸıäºÍ¹Ç׸ÐγÉÎªÌØÕ÷£¬³£Òý·¢»¼ÕßÊàŦÌÛÍ´¡¢½©Ö±¡¢¹¦Ð§Õϰ­¡£Òì³£Ó¦Á¦Ôغɡ¢Èí¹ÇϹDz¡±ä¡¢ÊàŦ»¬Ä¤Ñ×Ö¢µÈ¶àÒòËØµ¼ÖµÄOAÊàŦÈí¹Ç¾ÙÐÐÐÔÍ˱äÊÇOA²¡Àí¸Ä±äµÄÖÐÐÄ»·½Ú¡£ÏÖÔÚ¹¹½¨OA¶¯ÎïÄ£×ÓµÄÒªÁìͨ³£ÓÐÈýÖÖ£º¢ÙÍâ¿ÆÊÖÊõ»ò´´ÉË £»¢ÚÊàŦǻÄÚ×¢ÉäÒ©Îï £»¢ÛÓÕµ¼×Ô¾õÐÔOAÐγÉ¡£¿ÉÓÃÓÚÄ£×Ó¹¹½¨µÄ¶¯Îï°üÀ¨Ð¡Êó¡¢´óÊó¡¢ëàÊó¡¢Íá¢È®¡¢É½Ñò¡¢ÂíºÍСÐÍÖíµÈ¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î´óÊó¡¢¼ÒÍá¢È®¡¢É½Ñò

¡¾ÔìÄ £»úÖÆ¡¿£º

ÊàŦʧÎÈ¡¢¸ºÖØÊàŦÉúÎïÁ¦Ñ§ÔÓÂÒÊÇÒýÆðOA±¬·¢µÄÖ÷ÒªÔµ¹ÊÔ­ÓÉ£¬¿Éµ¼ÖÂÊàŦÈí¹Çϸ°ûÍ˱䣬½ø¶ø°ûÍâ»ùÖʽµ½â£¬×îÖÕÊàŦÈí¹ÇÍËÐÐÐԱ䡣ͨ¹ýÍâ¿ÆÊÖÊõijÈËΪ´´ÉËÒýÆðÊàŦʧȥÎȹÌÐÔ£¬ÊàÅ¦ÃæÏ໥½Ó´¥ÃæÓ¦Á¦¸Ä±äÒÔ¼°ÊàŦÄÚÑ×Ö¢·´Ó¦£¬´Ó¶øÓÕµ¼OA±¬·¢¡£¸ÃÖÖÔìÄ£ÒªÁìͨ³£ÌåÏÖµÄÊÇ´´É˺óOAµÄÐγÉÀú³Ì¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

½ÓÄÉǰ½»Ö¯ÈÍ´øºá¶ÏÊõ¡¢°ëÔ°åÇгýÊõ¡£Ì»Â¶ÊµÑ鶯ÎïÏ¥ÊàŦÊàŦǻºó¼á³ÖÓÞÃÁ£¬´¿´âºá¶Ïǰ½»Ö¯ÈÍ´ø»òÇгý°ëÔ°å¡£ÈôÐèÒªÑÏÖØOA¶¯ÎïÄ£×Ó£¬¿ÉÑ¡Ôñͬʱ½«ÄÚ²à°ëÔ°岿·ÖÇгý£¬»ò½«ÄÚ²à°ëÔ°åÁ¬Í¬ÄڲัÈÍ´øËùÓÐÇгý¡£½ÏΪ¾­µäµÄÊÖÊõÒªÁìΪHulth·¨£ºÑØÊµÑ鶯ÎïÏ¥ÊàŦÄÚ²à×ö×ÝÐÐÇпÚ£¬½«Ç°ºó½»Ö¯ÈÍ´ø¡¢ÄڲัÈÍ´øºá¶Ï£¬²¢ÇгýÄÚ²à°ë԰壬Ӧ¾¡Á¿×èÖ¹ËðÉËÊàŦÈí¹ÇÃæ¡£Êõºó¶¯Îï×ÔÓÉÔ˶¯¡£´óÊó¡¢¼ÒÍá¢È®¡¢É½ÑòµÈ¶¯Îï¾ù¿É½ÓÄÉ´ËÀàÊÖÊõÒªÁìÓÕµ¼ÊµÑ鶯ÎïOA±¬·¢¡£

¡¾Ä£×ÓÌØµã¡¿£º

1.´óÊóOAÄ£×Ó ÄÜÌåÏÖ³öÔçÆÚµÄÈí¹ÇÍË»¯¡¢Èí¹ÇϹÇïÔÌ­ºÍÍíÆÚ¹Ç׸ÐγÉ¡£Èí¹Ç°ûÍâ»ùÖÊÆÊÎöÂѰ×ø¾ÛÂѰ׶àÌÇø(aggrecanase)1ºÍ»ùÖʽðÊôÂѰ×ø(matrix metallopeptidase, MMP) 13±í´ïÏÔÖøÉý¸ß£¬µ¼ÖÂÈí¹Ç°ûÍâ»ùÖʽµ½âÔöÇ¿¡£µ«ÓÉÓÚ´óÊóÈí¹Ç²ã½Ïº££¬ÇÒÉú³¤°åÌØÊ⣬Èí¹Çϸ°ûÐÞ¸´ÄÜÁ¦½ÏÇ¿£¬Òò´ËÓÃÓÚOAµÄÑо¿ÉоßÓоÖÏÞÐÔ¡£

2.È®OAÄ£×Ó Êõºó8ÖÜÄÜÊӲ쵽¹Ç׸ÐγÉ£¬Èí¹ÇÆÆËð¡ £»ùÒò±í´ïˮƽÖ÷ÒªÌåÏÖΪÁ½ÖÖ¹ÇÎüÊÕÏà¹ØÂѰ×ø×éÖ¯ÂѰ×ø(cathepsin)KºÍMMP-13µÄ¸ß±í´ï¡£È®µÄÉú³¤°å½ÏΪ³ÉÊ죬Æä°ûÍâ»ùÖÊÆÊÎöÂѰ×øMMPsµÄ²¹ÌåºÍÆÊÎö²úÆ·¸üÀàËÆÓÚÈËÀàOA¡£

3.¼ÒÍÃOAÄ£×ӠԼĪÊõºó4ÖÜÄÜ·¢Ã÷Èí¹Ç·ºÆðÁѺۺÍÇÖÊ´£¬Èí¹ÇȱËðºÍ¹Ç׸ÐγÉͨ³£±¬·¢ÔڹɹÇ÷ÁºÍëÖ¹ÇÆ½Ì¨ÊàÅ¦Ãæ¡ £»ùÒò±í´ïת±äÉÏ£¬Ñª¹ÜÄÚÆ¤Éú³¤Òò×Ó(VEGF)±í´ïÒ»Á¬Éý¸ß£¬¿ÉÔö½øOAÈí¹Çϸ°ûºÏ³É¸ü¶àµÄMMP-1ºÍMMP-3£¬µ¼ÖÂÈí¹Ç°ûÍâ»ùÖʽµ½â¡£IL-1ºÍIL-1ÊÜÌå±í´ïÒ²ÏÔÖøÉϵ÷£¬¿ÉÒýÆðÈí¹Ç»ùÖÊÖÐÂѰ׶àÌǵÄÏÔ×ÅïÔÌ­¡£¼ÒÍõÄÊàŦÈí¹ÇԼĪÔÚ3ÔÂÁäʱ¾Í·¢Óý³ÉÊ죬Òò´Ë½ÏΪÊÊÏàÖúΪOAÄ£×Ó¡£

4.ɽÑòOAÄ£×Ó ÔÚɽÑò°ëÔ°åÇгýOAÄ£×ÓÖУ¬Êõºó3¸öÔÂÄÜÊӲ쵽µä·¶Èí¹ÇÍËÐÐÐԱ䡣ɽÑòµÄ°ëÔ°å½Ï´ó£¬ÇÒOAÖаëÔ°åËðÉ˲¡³ÌÓëÈËÀà¿¿½ü£¬½ÏÊʺϾÙÐÐOA°ëÔ°åÍ˱äµÄÑо¿¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

Íâ¿ÆÊÖÊõÓÕµ¼µÄOA¶¯ÎïÄ£×Ó¾ßÓÐÓÕµ¼Ê±¼ä¶Ì¡¢²¡³ÌÉú³¤½Ï¿ì¡¢ÊàŦÈí¹Ç½á¹¹¸Ä±äºÜÊÇÏÔ×ŵÄÌØµã£¬ÊõºóÊàŦ½Ï¿ìµÄÌåÏÖ³öÊàŦÄÚÑ×Ö¢·´Ó¦ºÍÑ×Ö¢Òý·¢µÄ½á¹¹ÆÆËð¡£Òò¶ø½ÏÁ¿ÊʺÏÑо¿ÒÖÖÆÈí¹ÇÍËÐÐÐÔ±äµÄÒ©ÎïЧӦµÄÏà¹ØÊµÑ顣ͬʱ£¬ÓÉÓÚÍâ¿ÆÊÖÊõͨ¹ýÔì³ÉÊàŦʧÎÈÒý·¢OA±¬·¢£¬ÊàÅ¦Ãæ²î±ð³ÐÖØ²¿Î»ÍùÍùÌåÏÖ³öÊÜËðµÄ²î±ðÐÔ£¬Òò´Ë£¬¹ØÓÚ¹Ø×¢´ËÀàÎÊÌâµÄÑо¿Õß¾ßÓиüºÃµÄÓ¦ÓüÛÖµ¡£

 

²Î¿¼ÎÄÏ×£º

1.ºú²¨£¬ºúÖ¾¿¡£¬ÕÅÓÐΪ£¬µÈ£®¹ÇÊàŦÑ×¶¯ÎïÄ£×Ó£ºÈ˹¤ÓÕµ¼Ó붯Îï×Ô¾õ£®Öйú×éÖ¯¹¤³ÌÑо¿ÓëÁÙ´²¿µ¸´£¬2010 14 (33):6202-6205

2.Chang DG,Iverson EP,Schinagl RM,et al. Quantitation and localization of cartiiage degeneration following the induction of osteoaritis in the rabbit knee. Osteoaritis Cartilage, 1997,5 (5):357-372

3.Jimenez PA,Glasson SS,Trubetskoy OV,et al. pontaneous osteoarthritis in Dunkin Hartley guinea pigs: histologic, radiologic, and biochemical changes. Lab Anim Sci, 1997,47 (6):598-601

4.Kyostio-Moore S, Nambiar B, Hutto E, et al. STR/orl mice, a model for spontaneous osteoarthritis, exhibit elevated levels of both local and systemic inflammatory markers. Comp Med,2011,61 (4):346-355

5.Little CB, Zaki S. What constitutes an "animal model of osteoaritis"-the need for consensus? Osteoarthritis Cartilage, 2012,20 (4):261-267

6.Longo UG, Loppini M, Furno C, el al. Osteoa.rthritis: new insights in animal models. Open Orthop J, 2012, 6: 558-563

7.Muraoka T, Hagino H,Okano T,el al. Role of subchondral bone in osteoaritis development: a comparative study of two strains of guinea pigs with and without spontaneously occurring osteoaritis. Arthritis Rheum,2007,56(10): 3366-3374

8.Pelletier JP, Boileau C, Brunet J, et al. The inhibition of subchondral bone resorption in lhe early phase of experimental dog osteoarthritis by licofelone is a55ociated with a reduction in the synthesis of MMP-13 and cathepsinK. Bone,2004,34(3):527-538

9.Piekarski M,Hayami T, Zhuo Y, el al. Molecular changes in articular cartilage and subchondral bone in Lhe rat anterior cruciate ligament transection and meniscectomizecl models of osteoarthritis. BMC MuscuJoskelet Disord,2011, 12: 197-200

10.Pomonis JD, Bowel JM, Goushall SL,et al. Development and pharmacological characterization of a rat model of osteoarthritis pain. Pain, 2005, 114 (3):339-346

11.Rogart JN. Barrach HJ Chichester CO. ArticuJar collagen degradalioa in the Hulth-Telhag model of osteoaritis. Osteoarthritis Cartilage, 1999,7 (6):539-547

12.Teeple E,Jay GD,Elsaid KA,et al. Animal morlels of osteoarthritis:challenges of model selection and analysis.AAPS J,2013, 15 (2):438-446

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Ƥ·ô¹Ç÷À¼¡ÏµÍ³Ä£×Ó > Íâ¿ÆÊÖÊõ»ò´´ÉË
Íâ¿ÆÊÖÊõ»ò´´ÉË

ǰÑÔ

¹ÇÊàŦÑ×(osteoarthritis, OA)ÊÇÖ÷ÒªÀÛ¼°ÖÐÍíÄêÈËȺµÄÂýÐÔÍËÐÐÐÔÊàŦ¼²²¡£¬ÒÔ¾ÙÐÐÐÔµÄÊàŦÈí¹ÇÍ˱䡢»¬Ä¤Ñ×Ö¢¡¢Èí¹ÇϹǸıäºÍ¹Ç׸ÐγÉÎªÌØÕ÷£¬³£Òý·¢»¼ÕßÊàŦÌÛÍ´¡¢½©Ö±¡¢¹¦Ð§Õϰ­¡£Òì³£Ó¦Á¦Ôغɡ¢Èí¹ÇϹDz¡±ä¡¢ÊàŦ»¬Ä¤Ñ×Ö¢µÈ¶àÒòËØµ¼ÖµÄOAÊàŦÈí¹Ç¾ÙÐÐÐÔÍ˱äÊÇOA²¡Àí¸Ä±äµÄÖÐÐÄ»·½Ú¡£ÏÖÔÚ¹¹½¨OA¶¯ÎïÄ£×ÓµÄÒªÁìͨ³£ÓÐÈýÖÖ£º¢ÙÍâ¿ÆÊÖÊõ»ò´´ÉË £»¢ÚÊàŦǻÄÚ×¢ÉäÒ©Îï £»¢ÛÓÕµ¼×Ô¾õÐÔOAÐγÉ¡£¿ÉÓÃÓÚÄ£×Ó¹¹½¨µÄ¶¯Îï°üÀ¨Ð¡Êó¡¢´óÊó¡¢ëàÊó¡¢Íá¢È®¡¢É½Ñò¡¢ÂíºÍСÐÍÖíµÈ¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î´óÊó¡¢¼ÒÍá¢È®¡¢É½Ñò

¡¾ÔìÄ £»úÖÆ¡¿£º

ÊàŦʧÎÈ¡¢¸ºÖØÊàŦÉúÎïÁ¦Ñ§ÔÓÂÒÊÇÒýÆðOA±¬·¢µÄÖ÷ÒªÔµ¹ÊÔ­ÓÉ£¬¿Éµ¼ÖÂÊàŦÈí¹Çϸ°ûÍ˱䣬½ø¶ø°ûÍâ»ùÖʽµ½â£¬×îÖÕÊàŦÈí¹ÇÍËÐÐÐԱ䡣ͨ¹ýÍâ¿ÆÊÖÊõijÈËΪ´´ÉËÒýÆðÊàŦʧȥÎȹÌÐÔ£¬ÊàÅ¦ÃæÏ໥½Ó´¥ÃæÓ¦Á¦¸Ä±äÒÔ¼°ÊàŦÄÚÑ×Ö¢·´Ó¦£¬´Ó¶øÓÕµ¼OA±¬·¢¡£¸ÃÖÖÔìÄ£ÒªÁìͨ³£ÌåÏÖµÄÊÇ´´É˺óOAµÄÐγÉÀú³Ì¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

½ÓÄÉǰ½»Ö¯ÈÍ´øºá¶ÏÊõ¡¢°ëÔ°åÇгýÊõ¡£Ì»Â¶ÊµÑ鶯ÎïÏ¥ÊàŦÊàŦǻºó¼á³ÖÓÞÃÁ£¬´¿´âºá¶Ïǰ½»Ö¯ÈÍ´ø»òÇгý°ëÔ°å¡£ÈôÐèÒªÑÏÖØOA¶¯ÎïÄ£×Ó£¬¿ÉÑ¡Ôñͬʱ½«ÄÚ²à°ëÔ°岿·ÖÇгý£¬»ò½«ÄÚ²à°ëÔ°åÁ¬Í¬ÄڲัÈÍ´øËùÓÐÇгý¡£½ÏΪ¾­µäµÄÊÖÊõÒªÁìΪHulth·¨£ºÑØÊµÑ鶯ÎïÏ¥ÊàŦÄÚ²à×ö×ÝÐÐÇпÚ£¬½«Ç°ºó½»Ö¯ÈÍ´ø¡¢ÄڲัÈÍ´øºá¶Ï£¬²¢ÇгýÄÚ²à°ë԰壬Ӧ¾¡Á¿×èÖ¹ËðÉËÊàŦÈí¹ÇÃæ¡£Êõºó¶¯Îï×ÔÓÉÔ˶¯¡£´óÊó¡¢¼ÒÍá¢È®¡¢É½ÑòµÈ¶¯Îï¾ù¿É½ÓÄÉ´ËÀàÊÖÊõÒªÁìÓÕµ¼ÊµÑ鶯ÎïOA±¬·¢¡£

¡¾Ä£×ÓÌØµã¡¿£º

1.´óÊóOAÄ£×Ó ÄÜÌåÏÖ³öÔçÆÚµÄÈí¹ÇÍË»¯¡¢Èí¹ÇϹÇïÔÌ­ºÍÍíÆÚ¹Ç׸ÐγÉ¡£Èí¹Ç°ûÍâ»ùÖÊÆÊÎöÂѰ×ø¾ÛÂѰ׶àÌÇø(aggrecanase)1ºÍ»ùÖʽðÊôÂѰ×ø(matrix metallopeptidase, MMP) 13±í´ïÏÔÖøÉý¸ß£¬µ¼ÖÂÈí¹Ç°ûÍâ»ùÖʽµ½âÔöÇ¿¡£µ«ÓÉÓÚ´óÊóÈí¹Ç²ã½Ïº££¬ÇÒÉú³¤°åÌØÊ⣬Èí¹Çϸ°ûÐÞ¸´ÄÜÁ¦½ÏÇ¿£¬Òò´ËÓÃÓÚOAµÄÑо¿ÉоßÓоÖÏÞÐÔ¡£

2.È®OAÄ£×Ó Êõºó8ÖÜÄÜÊӲ쵽¹Ç׸ÐγÉ£¬Èí¹ÇÆÆËð¡ £»ùÒò±í´ïˮƽÖ÷ÒªÌåÏÖΪÁ½ÖÖ¹ÇÎüÊÕÏà¹ØÂѰ×ø×éÖ¯ÂѰ×ø(cathepsin)KºÍMMP-13µÄ¸ß±í´ï¡£È®µÄÉú³¤°å½ÏΪ³ÉÊ죬Æä°ûÍâ»ùÖÊÆÊÎöÂѰ×øMMPsµÄ²¹ÌåºÍÆÊÎö²úÆ·¸üÀàËÆÓÚÈËÀàOA¡£

3.¼ÒÍÃOAÄ£×ӠԼĪÊõºó4ÖÜÄÜ·¢Ã÷Èí¹Ç·ºÆðÁѺۺÍÇÖÊ´£¬Èí¹ÇȱËðºÍ¹Ç׸ÐγÉͨ³£±¬·¢ÔڹɹÇ÷ÁºÍëÖ¹ÇÆ½Ì¨ÊàÅ¦Ãæ¡ £»ùÒò±í´ïת±äÉÏ£¬Ñª¹ÜÄÚÆ¤Éú³¤Òò×Ó(VEGF)±í´ïÒ»Á¬Éý¸ß£¬¿ÉÔö½øOAÈí¹Çϸ°ûºÏ³É¸ü¶àµÄMMP-1ºÍMMP-3£¬µ¼ÖÂÈí¹Ç°ûÍâ»ùÖʽµ½â¡£IL-1ºÍIL-1ÊÜÌå±í´ïÒ²ÏÔÖøÉϵ÷£¬¿ÉÒýÆðÈí¹Ç»ùÖÊÖÐÂѰ׶àÌǵÄÏÔ×ÅïÔÌ­¡£¼ÒÍõÄÊàŦÈí¹ÇԼĪÔÚ3ÔÂÁäʱ¾Í·¢Óý³ÉÊ죬Òò´Ë½ÏΪÊÊÏàÖúΪOAÄ£×Ó¡£

4.ɽÑòOAÄ£×Ó ÔÚɽÑò°ëÔ°åÇгýOAÄ£×ÓÖУ¬Êõºó3¸öÔÂÄÜÊӲ쵽µä·¶Èí¹ÇÍËÐÐÐԱ䡣ɽÑòµÄ°ëÔ°å½Ï´ó£¬ÇÒOAÖаëÔ°åËðÉ˲¡³ÌÓëÈËÀà¿¿½ü£¬½ÏÊʺϾÙÐÐOA°ëÔ°åÍ˱äµÄÑо¿¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

Íâ¿ÆÊÖÊõÓÕµ¼µÄOA¶¯ÎïÄ£×Ó¾ßÓÐÓÕµ¼Ê±¼ä¶Ì¡¢²¡³ÌÉú³¤½Ï¿ì¡¢ÊàŦÈí¹Ç½á¹¹¸Ä±äºÜÊÇÏÔ×ŵÄÌØµã£¬ÊõºóÊàŦ½Ï¿ìµÄÌåÏÖ³öÊàŦÄÚÑ×Ö¢·´Ó¦ºÍÑ×Ö¢Òý·¢µÄ½á¹¹ÆÆËð¡£Òò¶ø½ÏÁ¿ÊʺÏÑо¿ÒÖÖÆÈí¹ÇÍËÐÐÐÔ±äµÄÒ©ÎïЧӦµÄÏà¹ØÊµÑ顣ͬʱ£¬ÓÉÓÚÍâ¿ÆÊÖÊõͨ¹ýÔì³ÉÊàŦʧÎÈÒý·¢OA±¬·¢£¬ÊàÅ¦Ãæ²î±ð³ÐÖØ²¿Î»ÍùÍùÌåÏÖ³öÊÜËðµÄ²î±ðÐÔ£¬Òò´Ë£¬¹ØÓÚ¹Ø×¢´ËÀàÎÊÌâµÄÑо¿Õß¾ßÓиüºÃµÄÓ¦ÓüÛÖµ¡£

 

²Î¿¼ÎÄÏ×£º

1.ºú²¨£¬ºúÖ¾¿¡£¬ÕÅÓÐΪ£¬µÈ£®¹ÇÊàŦÑ×¶¯ÎïÄ£×Ó£ºÈ˹¤ÓÕµ¼Ó붯Îï×Ô¾õ£®Öйú×éÖ¯¹¤³ÌÑо¿ÓëÁÙ´²¿µ¸´£¬2010 14 (33):6202-6205

2.Chang DG,Iverson EP,Schinagl RM,et al. Quantitation and localization of cartiiage degeneration following the induction of osteoaritis in the rabbit knee. Osteoaritis Cartilage, 1997,5 (5):357-372

3.Jimenez PA,Glasson SS,Trubetskoy OV,et al. pontaneous osteoarthritis in Dunkin Hartley guinea pigs: histologic, radiologic, and biochemical changes. Lab Anim Sci, 1997,47 (6):598-601

4.Kyostio-Moore S, Nambiar B, Hutto E, et al. STR/orl mice, a model for spontaneous osteoarthritis, exhibit elevated levels of both local and systemic inflammatory markers. Comp Med,2011,61 (4):346-355

5.Little CB, Zaki S. What constitutes an "animal model of osteoaritis"-the need for consensus? Osteoarthritis Cartilage, 2012,20 (4):261-267

6.Longo UG, Loppini M, Furno C, el al. Osteoa.rthritis: new insights in animal models. Open Orthop J, 2012, 6: 558-563

7.Muraoka T, Hagino H,Okano T,el al. Role of subchondral bone in osteoaritis development: a comparative study of two strains of guinea pigs with and without spontaneously occurring osteoaritis. Arthritis Rheum,2007,56(10): 3366-3374

8.Pelletier JP, Boileau C, Brunet J, et al. The inhibition of subchondral bone resorption in lhe early phase of experimental dog osteoarthritis by licofelone is a55ociated with a reduction in the synthesis of MMP-13 and cathepsinK. Bone,2004,34(3):527-538

9.Piekarski M,Hayami T, Zhuo Y, el al. Molecular changes in articular cartilage and subchondral bone in Lhe rat anterior cruciate ligament transection and meniscectomizecl models of osteoarthritis. BMC MuscuJoskelet Disord,2011, 12: 197-200

10.Pomonis JD, Bowel JM, Goushall SL,et al. Development and pharmacological characterization of a rat model of osteoarthritis pain. Pain, 2005, 114 (3):339-346

11.Rogart JN. Barrach HJ Chichester CO. ArticuJar collagen degradalioa in the Hulth-Telhag model of osteoaritis. Osteoarthritis Cartilage, 1999,7 (6):539-547

12.Teeple E,Jay GD,Elsaid KA,et al. Animal morlels of osteoarthritis:challenges of model selection and analysis.AAPS J,2013, 15 (2):438-446

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿